DXR
Daxor Corporation
NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$11.40
+5.17% today
Updated 2026-09-11
Market cap
$58.84M
P/E ratio
6.15
P/S ratio
2,204.93x
EPS (TTM)
$1.64
Dividend yield
—
52W range
$9 – $15
Volume
0.0M
WallStSmart proprietary scores
45
out of 100
Grade: C
Sell
Investment rating
4.7
Growth
C4.8
Quality
C5.5
Profitability
C+6.7
Valuation
B2/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$22.50
+97.37%
12-Month target
$12.61
+10.61%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Profit margin 34,359.00% — above average
+ ROE 22.50% — strong efficiency
Risks
- Piotroski 2/9 — weak financial health
- Negative free cash flow $-2.51M
- Revenue declining -82.60% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.31M | $34.59M | $2.13M | $503424.00 | $26690.00 |
| Net income | $5.18M | $280640.00 | $536334.00 | $9.17M | $-3.31M |
| EPS | — | — | — | — | $1.64 |
| Free cash flow | $-769302.00 | $-3.66M | $25688.00 | $-604420.00 | $-2.51M |
| Profit margin | 82.06% | 0.81% | 25.17% | 1,821.48% | 34,359.00% |
Peer comparison
Smart narrative
Daxor Corporation trades at $11.40. representing a P/E of 6.15x trailing earnings. Our Smart Value Score of 45/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. TTM revenue stands at $26690.00. with profit margins at 34,359.00%.
Frequently asked questions
What is Daxor Corporation's stock price?
Daxor Corporation (DXR) trades at $11.40, on a P/E of 6.2x and a P/S of 2,204.9x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Daxor Corporation overvalued?
Daxor Corporation carries a Smart Value Score of 45/100 (Grade C), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Daxor Corporation (DXR)?
The 12-month analyst consensus target is $22.50, about 97.4% above the current $11.40. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Daxor Corporation's revenue?
Daxor Corporation's trailing twelve-month revenue is $26690.00. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2,204.93x
ROE22.50%
Beta0.27
50D MA$10.34
200D MA$11.32
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—